Mark Baldry X4 Pharmaceuticals, Inc (XFOR) insider trading activity

XFOR Quotes by TradingView

Mark Baldry is Chief Commercial Officer of X4 Pharmaceuticals, Inc. Currently has a direct ownership of 48,509 shares of XFOR, which is worth approximately $17,463. The most recent transaction as insider was on Oct 07, 2024, when has been sold 11,127 shares (Common Stock) at a price of $0.58 per share, resulting in proceeds of $6,453. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.5K
96.47% 3M change
96.47% 12M change
Total Value Held $17,463

Mark Baldry Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 07 2024
SELL
Open market or private sale
$6,453 $0.58 p/Share
11,127 Reduced 18.66%
48,509 Common Stock
Oct 04 2024
BUY
Grant, award, or other acquisition
-
34,946 Added 36.95%
59,636 Common Stock
Nov 01 2023
SELL
Open market or private sale
$7,487 $0.73 p/Share
10,257 Reduced 29.35%
24,690 Common Stock
Oct 31 2023
BUY
Grant, award, or other acquisition
-
34,947 Added 50.0%
34,947 Common Stock
MB

Mark Baldry

Chief Commercial Officer
Boston, MA

Track Institutional and Insider Activities on XFOR

Follow X4 Pharmaceuticals, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XFOR shares.

Notify only if

Insider Trading

Get notified when an X4 Pharmaceuticals, Inc insider buys or sells XFOR shares.

Notify only if

News

Receive news related to X4 Pharmaceuticals, Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XFOR